CC0 PUBLIC RECORD GRAPH Every score & timeline item links directly to its underlying U.S. FDA record (openFDA, ORA FOIA Reading Room, DECRS & OASIS).
Scoring Formula v2.0 & Legal Guardrails REST API v1
FG
GMPGraphv2.0
Global FDA Facility Graph & Co-Packer Intelligence
Recalls → D-0051-2027
Class II Recall · D-0051-2027 Report Date: 2026-10-28 · Status: Ongoing

Pfizer — Pharmaceuticals & Sterile/OTC Drugs Recall

Product Description: Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10
Reason for Recall: Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
Distribution Pattern: US Nationwide and Puerto Rico
View Linked Facility Profile (FEI FEI-59D52EE6) → Verify on openFDA ↗